Core Viewpoint - The article discusses the reliability of brokerage recommendations, particularly focusing on Merck (MRK), and highlights the potential misalignment of interests between brokerage analysts and retail investors [1][10]. Group 1: Brokerage Recommendations for Merck - Merck has an average brokerage recommendation (ABR) of 1.92, indicating a consensus between Strong Buy and Buy, based on recommendations from 25 brokerage firms [2]. - Out of the 25 recommendations, 13 are Strong Buy (52%) and 1 is Buy (4%) [2]. Group 2: Limitations of Brokerage Recommendations - Studies indicate that brokerage recommendations have limited success in guiding investors towards stocks with the best price increase potential [5]. - Analysts from brokerage firms tend to exhibit a strong positive bias in their ratings, issuing five "Strong Buy" recommendations for every "Strong Sell" [6][10]. - The interests of brokerage firms may not align with those of retail investors, leading to potential misguidance regarding stock price movements [7][10]. Group 3: Zacks Rank as an Alternative - Zacks Rank categorizes stocks into five groups based on earnings estimate revisions, providing a more effective indicator of near-term stock price performance compared to ABR [8][11]. - The Zacks Rank is updated more frequently than ABR, reflecting timely changes in earnings estimates and business trends [12]. Group 4: Current Earnings Estimates for Merck - The Zacks Consensus Estimate for Merck's earnings for the current year remains unchanged at $8.92, suggesting stable analyst views on the company's earnings prospects [13]. - Due to the unchanged consensus estimate and other factors, Merck holds a Zacks Rank of 3 (Hold), indicating a cautious approach despite the Buy-equivalent ABR [14].

Group 1 - Terns Pharmaceuticals, Inc. (TERN) has experienced a significant downtrend, with a stock decline of 39.8% over the past four weeks, indicating excessive selling pressure [1] - The stock is currently in oversold territory, as evidenced by an RSI reading of 21.87, suggesting a potential reversal in trend [5] - Wall Street analysts have shown strong agreement in raising earnings estimates for TERN, with a 6.5% increase in the consensus EPS estimate over the last 30 days, which typically correlates with price appreciation [7] Group 2 - TERN holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, indicating a strong potential for a turnaround [8]

截至 9 月底的财季里，Google 母公司（GOOGL）营收 882.68 亿美元、同比增长 15%，净利润 263.01 亿美元、同比增长 34%。超预期的增长来自借力 AI 的云业务，三季度收入增长 35% 至 113.51 美元。公布财报后，股票盘后上涨 6.9%。 亚洲市场降温，Moncler 三季度收入转跌。 今年前三季度收入增长 6% 的基础上，意大利奢侈品集团 Moncler（MONC.MI）第三季度收入下跌 3% 至 6.4 亿欧元，集团核心品牌 Moncler 三季度收入下跌 3%。品牌在各地区的销售额均下降，其 中最大市场亚洲的下降原因除了消费者信心不足，还有赴日旅游人数回落。Moncler 集团上个月获 LVMH 投资，三季度前曾是今年奢侈品行业集体遇冷下的 "黑马"。 马斯克的大模型公司继续融资，距上一轮仅 5 个月。 据媒体报道，马斯克的 xAI 正以 400 亿美元估值寻求融资。前一轮 5 月的融资里，xAI 拿到 60 亿 美元、估值 240 亿美元。这家公司一年半以前创立，旗下大模型 Grok 的最新功能包括创建应用程 序和生成图像。大模型行业里，OpenAI 本月筹集 66 ...